Studies›Active Protocols

Active Protocols

Active protocol workspaces, enrollment pressure, sites, and generated visit schedules.

9 protocols

Study	Sponsor	Phase	Indication	Status	Enrollment	Sites
APEX-T2Dv1Type 2 Diabetes Phase III	Astellar Biosciences	Phase III	Type 2 Diabetes Mellitus	Recruiting	8/180	3
CARDIO-118v1Hypertension Device Study	Meridian Device Labs	Device	Uncontrolled essential hypertension	Draft review	0/60	1
CLARITY-HTNv1Hypertension Phase II	ClearPath Therapeutics	Phase II	Essential Hypertension	Enrollment closed	0/120	2
DPN-204v1Diabetic Neuropathy Pain Study	Algesia Therapeutics	Phase II	Painful diabetic peripheral neuropathy	Recruiting	0/144	3
NEURO-247v1Cognitive Resilience Pharmacotherapy Trial	Axiom Therapeutics, Inc.	Phase II	Mild cognitive impairment associated with early neurodegenerative disease	Draft review	0/80	2
NOVEX-AFv1Atrial Fibrillation Phase II	NovaRhythm Pharma	Phase II	Atrial Fibrillation	Recruiting	0/96	2
PN-CHRONICv1Chronic Neuropathic Pain Phase III	Meridian Therapeutics	Phase III	Chronic Neuropathic Pain	Draft review	0/210	3
RENEW-COPDv1COPD Phase III	Renewel Biosciences	Phase III	Chronic Obstructive Pulmonary Disease	Draft review	0/240	4
RESP-501v1Severe Asthma Phase III Study	BronchiCare Pharma	Phase III	Moderate persistent asthma	Draft	0/300	—